We are putting forward a model.

Modern medicine has been remarkably successful at describing disease. Yet many chronic conditions continue to cluster together. Obesity, insulin resistance, fatty liver disease, cardiovascular disease, neurodegeneration, and cancer are typically treated as distinct problems, but they often emerge in the same individuals and environments.

This raises a simple question: are these truly separate conditions, or different expressions of the same underlying constraint?

We are publishing this model publicly because scientific ideas become stronger when challenged.

THE THESIS

Many chronic diseases may not be separate conditions, but different expressions of the same underlying constraint: a breakdown in how cells produce and use energy.
Fructose metabolism may represent one important contributor to that constraint.

Challenge the Model →

Submit evidence, critiques, or alternative explanations →

§ 01 — The Claim

A unifying hypothesis.

Most chronic diseases are classified according to the tissues they affect. This model asks whether many of those conditions might instead reflect different manifestations of the same constraint.

In this view, the diagnosis is not the starting point. It is the outcome. What appears as fatty liver disease in one person, cardiovascular disease in another, or neurodegeneration in a third may reflect the same deeper pattern expressed in different tissues.

The names change. The pattern may not.

If you've spent time thinking about this space, your perspective is valuable. We are interested not only in support for this model, but also in the strongest arguments against it.

It is a unifying claim. A testable one. We're inviting it to be challenged.

§ 02 — THE SHARED CONSTRAINT

Cellular energy as a common denominator.

A growing body of research suggests that impaired cellular energy availability may be a common feature across many chronic diseases. This idea is not unique to this model.

This idea is not unique to this model. What this framework attempts to explain is why that energetic pattern appears so consistently across seemingly unrelated diseases.

§ 03 — A Proposed Mechanism

Fructose metabolism as a convergent pathway.

There are many possible drivers of cellular energy disruption. This model focuses on one in particular: fructose metabolism.

Unlike glucose, fructose bypasses key regulatory steps in cellular metabolism and can rapidly consume cellular energy, increase uric acid, and alter mitochondrial function.

Under repeated or high-flux conditions, this pathway may act as an energetic sink, making it more difficult for cells to maintain the energy required for repair and normal function.

Importantly, fructose exposure is not limited to diet. Under conditions such as hyperglycemia or osmotic stress, the body can generate fructose internally via the polyol pathway, feeding the same metabolic process.

Fig. 01 — The convergent pathway

UPSTREAM ↓ DOWNSTREAM ↓ DIETARY FRUCTOSE HYPERGLYCEMIA OSMOTIC STRESS POLYOL PATHWAY REPEATED EXPOSURE KHK FRUCTOSE METABOLISM — bottleneck — INSULIN RESISTANCE NAFLD CARDIOVASCULAR NEURODEGEN. PCOS INFLAMMATION
UPSTREAM ↓ DIETARY FRUCTOSE HYPERGLYCEMIA OSMOTIC STRESS POLYOL PATHWAY REPEATED EXPOSURE KHK FRUCTOSE METABOLISM INSULIN RESISTANCE NAFLD CARDIOVASCULAR NEURODEGEN. PCOS INFLAMMATION DOWNSTREAM ↓

Multiple upstream stressors converge through KHK-mediated fructose metabolism, then diverge into tissue-specific chronic-disease patterns.

Fructose metabolism may act as a convergent pathway, linking multiple upstream stressors to a shared energetic outcome.

§ 04 — Supporting Work

Read the framework in full.

This model has been developed as a synthesis of existing research and known biological mechanisms. For those who want to explore the full framework, we've published a preprint outlining the system in more detail.

The KHK–Polyol Axis

Preprint · DOI

A Convergent Energetic Bottleneck in Chronic Disease Persistence

doi.org/10.32388/R2NFG9

Read the preprint →

This is an evolving model, and we expect it to change as stronger data emerges.

§ 05 — This May Be Wrong

Not settled science. A working model.

This is not presented as settled science. It is a working model.

And like any model, it should be tested, challenged, and, if necessary, revised or replaced.

We are actively looking for that.

§ 06 — What Would Disprove It

Useful counterarguments, specifically.

Not all criticism is equally useful.

We are specifically looking for challenges that address the structure of the model. For example:

  1. 01

    Evidence that cellular energy impairment does not meaningfully contribute to chronic disease patterns.

  2. 02

    Evidence that fructose metabolism does not significantly impact cellular energy under relevant conditions.

  3. 03

    Evidence that endogenous fructose production is insufficient to influence cellular energy in real-world physiology.

  4. 04

    A more complete model that explains the same range of observations with fewer assumptions.

Strong counterarguments help refine or invalidate the model. Both outcomes are valuable.

§ 07 — Submit a Challenge

If we're wrong, show us where.

If you believe this model is incomplete, incorrect, or misleading, we want to see it. Submit your critique below.

Reviewed by Chris Mearns · LIV3 research team

Prefer email? Send your critique directly to research@liv3health.com.

§ 08 — What Happens Next

Reviewed publicly. Within 2–4 weeks.

Submissions are reviewed directly by Chris Mearns and the LIV3 research team.

Substantive critiques are addressed publicly through articles or videos, with responses typically published within 2–4 weeks .

This model will either strengthen under pressure, or be replaced by a better explanation. Both outcomes are useful.

Context

This page outlines a scientific model based on existing research. It is intended for scientific discussion and critique. Nothing on this page is medical advice, and no statements here should be construed as claims that any product diagnoses, treats, cures, or prevents any disease. For health questions, consult a qualified healthcare professional.

My Cart
0